- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04869462
DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) (DOSTILCU)
Prospective, Monocentric, Single Arm, Observational PMCF - Study on the Performance and Safety of Double-Shank Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
Study Overview
Status
Detailed Description
The objective of this observational study is to collect systematically and proactively data regarding the Aesculap® DS Titanium Ligation Clip under daily clinical practice when used in urology in different indications.
The hypothesis of this study is that this event, slippage / movement of the clip, is extremely rare through the design if used in accordance with the Instructions for Use (IfU). The observed rate through the total number of clips might be a valuable parameter and could influence future research.
Furthermore, this study is one of the PMCF measures which enable the manufacturer to monitor the safety and performance of the Aesculap® DS Titanium Ligation Clips. The products bear the CE-marking and are routinely used within this institution for the above-mentioned procedures.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Offenburg, Germany, 77654
- Ortenau Klinikum Klinik für Urologie und Kinderurologie
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion: Inclusion Criteria:
- Planned Da Vinci radical prostatectomy using DS Titanium Ligation Clips (according to the IfU) - OR
- Planned laparoscopic nephrectomy using Titanium Ligation Clip (according to the IfU) - OR
- Planned Da Vinci partial nephrectomy using Titanium Ligation Clip (according to the IfU)
- Patient's written informed consent
- Age ≥ 18 years
- Intraoperative Usage of DS Titanium Ligation Clips (according to the IfU)
Exclusion: Exclusion Criteria:
• None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of slippage / movement of the clip in relationship to the total number of used clips.
Time Frame: Intraoperatively
|
Slippage / movement of the Aesculap® DS Titanium Ligation Clip is an observable slippage, movement, or rotation after the clip was successfully applied and the application forceps was removed. The number of observed slippage / movement of the clip will be documented on the CRF, the clip size, step of the procedure and further measures were necessary, i.e. removal of the clip or application of another clip, will be documented. In the end the rate will be brought in relationship to the overall number of applied clips. Thus, the number of applied clips is documented, for each clip size. |
Intraoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Adverse events (intra- and postoperative)
Time Frame: up to discharge from hospital (approximately 10 days post surgery)
|
|
up to discharge from hospital (approximately 10 days post surgery)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative blood loss
Time Frame: intraoperatively
|
Estimated intraoperative blood loss
|
intraoperatively
|
|
Total operative time
Time Frame: intraoperatively
|
Estimated operative time from first cut to last stitch
|
intraoperatively
|
|
Length of hospital stay
Time Frame: up to discharge from hospital (approximately 10 days post surgery)
|
Length of patient's stay in hospital after surgery
|
up to discharge from hospital (approximately 10 days post surgery)
|
|
Handling parameters
Time Frame: intraoperatively
|
The handling performance of the clip is assessed on a five point likert scale (very good, good, acceptable, poor) in four different handling aspects
|
intraoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jörg Simon, PD Dr. med., Ortenau KlinikumKlinik für Urologie und Kinderurologie ChefarztEbertplatz 1277654 Offenburg
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Infections
- Neoplasms
- Urologic Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Kidney Diseases
- Urologic Diseases
- Bacterial Infections
- Bacterial Infections and Mycoses
- Gram-Positive Bacterial Infections
- Actinomycetales Infections
- Pathological Conditions, Anatomical
- Mycobacterium Infections
- Urolithiasis
- Urinary Calculi
- Calculi
- Tuberculosis, Urogenital
- Kidney Neoplasms
- Congenital Abnormalities
- Tuberculosis
- Nephritis
- Kidney Calculi
- Nephrolithiasis
- Hydronephrosis
- Tuberculosis, Renal
Other Study ID Numbers
- AAG-O-H-2041
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Cancer
-
Guliz OzgunBritish Columbia Cancer AgencyNot yet recruiting
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnKidney/Urinary Cancer
-
Tianjin Medical University Second HospitalRecruiting
-
Tianjin Medical University Second HospitalRecruiting
-
Cedars-Sinai Medical CenterRecruitingProstate Cancer Stage II | Prostate Cancer Stage I | Bladder Cancer Stage II | Kidney Cancer Stage IUnited States
-
Intuitive SurgicalCompleted
-
Dana-Farber Cancer InstituteCompletedKidney Cancer | Prostate Cancer | Genitourinary CancerUnited States
-
University of Texas Southwestern Medical CenterCompletedKidney Cancer | Kidney Cancer Metastatic | Kidney Cancer, Stage IVUnited States
-
Yale UniversityCompleted
-
Stanford UniversityNational Cancer Institute (NCI)WithdrawnProstate Cancer | Bladder Cancer | Kidney Tumor